Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term anticoagulation. Indications and management.

B M Stults, W H Dere, T H Caine

    The Western Journal of Medicine
    |October 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical efficacy of SERMs.

    Aging (Milan, Italy)·1998
    Same author

    Selective estrogen receptor modulators: an alternative to hormone replacement therapy.

    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)·1998
    Same author

    Development and implementation of a computer-generated reminder system for diabetes preventive care.

    Proceedings. Symposium on Computer Applications in Medical Care·1994
    Same author

    Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah.

    American journal of hypertension·1993
    Same author

    Familial dyslipidaemic hypertension and other multiple metabolic syndromes.

    Annals of medicine·1992
    Same author

    Cefaclor advanced formulation versus cefaclor in the treatment of pneumonia.

    Clinical therapeutics·1992

    Anticoagulant therapy prevents thromboembolism but requires careful management. Optimizing anticoagulant intensity and monitoring for bleeding risks are crucial for safe and effective treatment.

    Area of Science:

    • Pharmacology
    • Thrombosis Management
    • Patient Safety

    Background:

    • Anticoagulant therapy is widely used to prevent thromboembolism, affecting half a million individuals annually in the U.S.
    • Current guidelines for anticoagulant use in various thromboembolic disorders lack consensus, particularly regarding optimal intensity.
    • Understanding the benefits and risks of anticoagulation is essential for clinical decision-making.

    Purpose of the Study:

    • To review and clarify the benefits and risks of anticoagulant therapy.
    • To discuss the complexities and controversies in anticoagulant dosing and monitoring.
    • To highlight key considerations for safe and effective anticoagulant administration.

    Main Methods:

    • Review of recent research and analytic reviews on anticoagulant therapy.

    Related Experiment Videos

  • Analysis of expert panel recommendations and areas of disagreement.
  • Examination of risk factors and diagnostic evaluation for anticoagulant-induced hemorrhage.

    • Main Results:

    • Disagreements persist among expert panels regarding the optimal intensity of anticoagulation.
    • Research has improved understanding of risk factors and diagnosis of anticoagulant-induced hemorrhage.
    • Non-hemorrhagic complications, especially during pregnancy, require clinical awareness.

    Conclusions:

    • Effective anticoagulant therapy necessitates a thorough understanding of drug pharmacology.
    • Organized long-term monitoring and comprehensive patient education are vital for safe anticoagulation.
    • Addressing complexities in dosing and monitoring can facilitate better patient outcomes.